A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.

Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito T, Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE, Meltzer SJ
Cancer Res. 2009 69 (10): 4112-5

PMID: 19435894 · PMCID: PMC2752375 · DOI:10.1158/0008-5472.CAN-09-0028

MeSH Terms (20)

Age Factors Barrett Esophagus Biomarkers Core Binding Factor Alpha 3 Subunit Cyclin-Dependent Kinase Inhibitor p16 Disease Progression Double-Blind Method Endoscopy Esophageal Neoplasms Gene Expression Regulation Gene Expression Regulation, Neoplastic Humans Membrane Proteins Neoplasm Proteins Polymerase Chain Reaction Predictive Value of Tests Promoter Regions, Genetic Reproducibility of Results Risk Assessment ROC Curve

Connections (1)

This publication is referenced by other Labnodes entities: